Mycophenolate mofetil (MMF)/tacrolimus (FK506) is an effective and safe regimen for graft versus host disease (GVHD) prophylaxis in pediatric allogeneic stem cell transplant (AlloSCT) recipients: Altered MMF pharmacokinetics (PK) and association with acute GVHD

被引：0
|
作者：
Osunkwo, I [1 ]
Bessmertny, O [1 ]
Harrison, L [1 ]
Garvin, J [1 ]
George, D [1 ]
Bradley, MB [1 ]
DelToro, G [1 ]
Wischhover, C [1 ]
Wolownik, K [1 ]
van de Ven, C [1 ]
Cheung, YK [1 ]
Cairo, MS [1 ]
机构：
[1] Columbia Univ, New York, NY 10027 USA
来源：
PEDIATRIC RESEARCH | 2003年 / 53卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
2988
引用
收藏
页码：528A / 528A
页数：1
相关论文
共 50 条
  • [1] Tacrolimus (FK-506) and mycophenolate mofetil (MMF) GVHD prophylaxis in pediatric allogeneic SCT (AlloSCT) recipients: Altered MMF pharmacokinetics (PK) associated with acute (A)GVHD
    Bessmertny, O
    Farris, K
    van de Ven, C
    Harrison, L
    Osunkwo, I
    Wolownik, K
    Garvin, J
    George, D
    Del Toro, G
    Bradley, MB
    Cheung, YK
    Skerrett, D
    Cairo, MS
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 103 - 103
  • [2] Tacrolimus (FK-506) and mycophenolate mofetil (MMF) GVHD prophylaxis in pediatric allogeneic SCT (AlloSCT) recipients: Altered MMF pharmacokinetics (PK) associated with acute (A)GVHD.
    Bessmertny, O
    Farris, K
    van de Ven, C
    Harrison, L
    Osunkwo, I
    Wolownik, K
    Garvin, J
    George, D
    Del Toro, G
    Bradley, MB
    Skerrett, D
    Cairo, MS
    [J]. BLOOD, 2003, 102 (11) : 713A - 713A
  • [3] Tacrolimus (FK506) and mycophenolate mofetil (MMF) is a safe and potentially effective alternative GVHD prophylaxis regimen in related (R) and unrelated (UR) donor allogeneic SCT (AlloSCT).
    Cairo, MS
    Harrison, LA
    Ellis, H
    Wolownik, K
    Del Toro, G
    Bradley, MB
    Yamashiro, DJ
    Garvin, JH
    [J]. BLOOD, 2001, 98 (11) : 662A - 663A
  • [4] Pharmacokinetics (PK) of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant (AlloSCT) recipients
    Militano, O.
    Hedgpeth, D.
    Shaw, L. M.
    Figurski, M.
    Satwani, P.
    Ayello, J.
    Roman, E.
    Bradley, B.
    George, D.
    Garvn, J.
    Bhatia, M.
    Wolownick, K.
    Foley, S.
    Hawkes, R.
    Cairo, M. S.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 114 - 115
  • [5] Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic stem cell transplantation
    Kasper, C
    Mügge, L
    Schilling, K
    Scholl, S
    Wollina, K
    Höffken, K
    Sayer, H
    [J]. BONE MARROW TRANSPLANTATION, 2002, 29 : S187 - S188
  • [6] PHARMACOKINETICS OF MYCOPHENOLATE MOFETIL (MMF) IN COMBINATION WITH TACROLIMUS IN PEDIATRIC ALLOGENEIC STEM CELL TRANSPLANT (ALLOSCT) RECIPIENTS ≤ 12 YEARS OF AGE
    Militano, O.
    Bhatia, M.
    Figurski, M.
    Shaw, L.
    Geyer, M. B.
    Jacobson, J. S.
    Morris, F.
    Satwani, P.
    George, D.
    Garvin, J. H.
    Cairo, M. S.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S191 - S191
  • [7] Pharmacokinetics (PK) of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant (AlloSCT) recipients are associated with significantly higher clearance
    Militano, O
    Roache, K
    Shaw, LM
    Figurski, M
    Satwani, P
    Ayello, J
    Wolownik, K
    Foley, S
    Hawkes, R
    Del Toro, G
    Bradley, MB
    George, D
    Garvin, J
    Bhatia, M
    Roman, L
    Cairo, MS
    [J]. BLOOD, 2005, 106 (11) : 518A - 518A
  • [8] Combined tacrolimus (FK-506) and mycophenolate mofetil (MMF) for graft-versus-host disease (GVHD) prophylaxis in children undergoing cord blood transplantation (CBT)
    Soni, S.
    Hente, M.
    Breslin, N.
    Bertolone, S.
    Cheerva, A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 66 - 66
  • [9] Daclizumab (DAC) ± mycophenolate mofetil (MMF) for control of graft-versus-host disease (GVHD) in allogeneic stem cell transplant patients with cyclosporine or tacrolimus intolerance.
    Abhyankar, S
    Day, SD
    Barnhart, C
    Belt, RJ
    McGuirk, JP
    [J]. BLOOD, 2001, 98 (11) : 353B - 353B
  • [10] Mycophenolate Mofetil (MMF) [900 MG/M2 Q8H] in Combination with Tacrolimus Is Effective to Prevent Acute and Chronic Gvhd Pediatric Allogeneic Stem Cell Transplant (AlloSCT) Recipients
    Militano, Olga
    Mitchell, Daniel
    Ours, Christopher
    Morris, Erin
    Wolownik, Karen
    Foley, Sandra
    Leclere, Jennie
    van de Ven, Carmella
    Cairo, Mitchell S.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S176 - S176
12345